KC-2567

ID8-EPCAM Cell Line

×
24314
Home » ID8-EPCAM Cell Line

Background of ID8-EPCAM Cell Line

EPCAM encodes epithelial cell adhesion molecule and is also known as ESA. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy.

Specifications

Catalog NumberKC-2567
Cell Line NameID8-EPCAM Cell Line
NCBI/UniProt Accession NumberNM_002354.2
Clone NumberNA
Host Cell LineID8
DescriptionID8-EPCAM is a stable engineered cell line expressing human EPCAM
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10%FBS+2μg/mL puro
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

ID8-EPCAM cell line was generated using a lentiviral vector expressing the human EPCAM sequence.

Characterization

Figure 1: Characterization of EPCAM overexpression in the ID8-EPCAM stable clone using FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Hosseinzadeh MH, Askarzadeh M, Ebrahimnejad P et al. Innovative approaches in the therapeutic application of EpCAM aptamer for targeted cancer treatment: A review. Biochimica et biophysica acta. General subjects. 2026 Oct;1870(10):130982. PMID: 42498054. doi: 10.1016/j.bbagen.2026.130982.
  2. Ghari M, Ghaemimanesh F EpCAM: A multifunctional protein at the crossroads of cancer biology, diagnosis, and immunotherapy. Cancer treatment and research communications. 2026;48:101258. PMID: 42235112. doi: 10.1016/j.ctarc.2026.101258.
  3. Huang Z, Li Y, Li M et al. Emerging Applications of EpCAM-Targeted Nuclear Medicine Probes: Current Research and Future Perspectives. International journal of nanomedicine. 2025;20:10815-10830. PMID: 40927663. doi: 10.2147/IJN.S539010.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.